ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 165 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -100.0% | 76,300 | +63.0% | 0.00% | -100.0% |
| Q3 2022 | $15,000 | +7.1% | 46,800 | -43.0% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | +250.0% | 82,100 | -19.0% | 0.00% | – |
| Q1 2022 | $4,000 | +33.3% | 101,300 | +151.4% | 0.00% | – |
| Q4 2021 | $3,000 | -76.9% | 40,300 | -26.3% | 0.00% | – |
| Q3 2021 | $13,000 | +160.0% | 54,700 | +147.5% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 22,100 | -70.2% | 0.00% | – |
| Q4 2020 | $5,000 | -97.8% | 74,200 | +44.5% | 0.00% | -100.0% |
| Q2 2019 | $224,000 | +833.3% | 51,342 | +99.0% | 0.02% | +800.0% |
| Q1 2019 | $24,000 | +140.0% | 25,800 | +8.9% | 0.00% | +100.0% |
| Q4 2016 | $10,000 | +900.0% | 23,700 | -21.0% | 0.00% | – |
| Q3 2014 | $1,000 | -96.6% | 30,000 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $29,000 | -23.7% | 30,000 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $38,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |